LOS ANGELES--(BUSINESS WIRE)--
The Law Offices of Todd M. Garber announces that it is investigating potential claims against Amyris, Inc. (AMRS) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by Amyris between April 29, 2011 and February 8, 2012 regarding the Company’s business, operations and prospects.
Amyris is a renewable products company engaged in the provision of various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. The Company builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The investigation is related to the Company’s February 9, 2012 disclosure that Amyris no longer planned to complete expansion of one of its 100-million liter production facilities. The Company further disclosed that through 2011 Amyris experienced “a significant number of operational issues” at the Company’s Biomin contract manufacturing site. Following these disclosures, Amyris stock fell from $9.73 per share on February 9, 2012, to close at $6.99 per share on February 10, 2012, on unusually heavy trading volume.
If you purchased Amyris shares during the foregoing period, if you have information or would like to learn more about these claims, or if you purchased Amyris stock prior to April 29, 2011 and wish to discuss these matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to firstname.lastname@example.org.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Todd M. Garber, Attorney at Law
Los Angeles, California